Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Close the GAP
NCT04542148Phase 2Active, not recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Feb 2022
- Primary completion
- Nov 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of human insulin in gestational diabetes mellitus (GDM), type 2 diabetes mellitus (T2DM), sponsored by University of Alabama at Birmingham. Started Feb 2022; status: active, not recruiting.
02
Drugs
human insulin
03
Conditions
gestational diabetes mellitus (GDM)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04542148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04542148.